Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser

Determine if Cetaphil Daily Facial Cleanser is a contact sensitizer or irritant to the skin

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Skin Irritation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

AMA Laboratories

New City, New York, 10956, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Not currently under a doctor's care
Free of dermatological or systemic disorder which would interfere with the results
Free of any acute or chronic disease
Will complete a preliminary medical history form and are in general good health
Can read, understand, and sign informed consent

Exclusion criteria

Under 18 years old
Currently under doctor's care
Currently taking any medication
History of acute or chronic disease
Diagnosed with chronic skin allergies
Pregnant or lactating

Treatment and study plan

Cetaphil Daily Facial Cleanser

Other

Primary outcomes

area of erythema and edema to test reaction of skin to product

Time frame: 3 consecutive weeks

9 consecutive 24hr exposures for every Monday, Wednesday, and Friday for 3 consecutive weeks will be conducted to test the reaction of the skin to the test product

Sponsors and collaborators

Lead sponsor

Galderma R&D

Industry

Registry information

Official study title

Cetaphil Daily Facial Cleanser: 200 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation

Important dates

Study start: 2012
Primary completion: 2013
First posted: Jun 28, 2013
Registry last updated: Jul 29, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed